EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Chemokines and Their Association With Symptom Severity in Women With Endometriosis

Anton Sommar, Pinar Yalcin Bahat, Ipek Yildiz Özaydin, Eray Metin Güler, Marie Bixo, Torbjörn Bäckström, Engin Oral, Sahruh Turkmen

American Journal of Reproductive Immunology · 2025-09 · 94 (3)

DOI: 10.1111/aji.70156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, online erschienen am 04.09.2025. Verfasst von Anton Sommar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Obstetrics and Gynecology, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Endometriosis, Endometrium, Chemokine CXCL1, Chemokines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Research and Development (FOU), Region Västernorrland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Problem Various chemokines have been linked to endometriosis. Notably, chemokines such as CCL2, CXCL8, and CXCL1 have also been shown to promote nociception. In this study, we investigated whether increased serum concentrations and endometrial expression of chemokines (specifically CCL2, CXCL8, and CXCL1) are associated with heightened severity of pain symptoms in women with endometriosis. Method of Study The study included women with endometriosis (with [ n = 27] and without [ n = 24] hormonal treatment) as well as healthy controls ( n = 22). All participants underwent blood sampling and an endometrial biopsy during the secretory phase of the menstrual cycle. Symptom severity in the patient group was assessed using the pain dimension of the Endometriosis Health Profile 30 (EHP‐30) and a visual analog scale (VAS) for pain.

Results

Serum levels of CCL2 and CXCL1, as well as endometrial expression of CXCL8, were lower in women with endometriosis compared to controls. Furthermore, increased serum levels of CCL2, CXCL8, and CXCL1 were associated with higher EHP‐30 pain domain scores in women with endometriosis. Similarly, elevated endometrial expression of CXCL8 and CXCL1 correlated with higher VAS scores. Notably, when the patient group was stratified based on ongoing hormonal treatment, CXCL1 emerged as the most promising target, with both increased serum concentration and endometrial expression consistently being associated with greater symptom severity.

Conclusions

Our results suggest that chemokines, particularly CXCL1, are associated with greater pain severity and reduced quality of life in women with endometriosis. However, these correlations do not establish causality and should be interpreted with caution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisEndometriumChemokine CXCL1ChemokinesInterleukin-8Chemokine CCL2PainHumansFemaleAdultSeverity of Illness IndexYoung Adult

Stichwörter der Autor:innen

CCL2CXCL1CXCL8chemokineendometriosispain

Substanzen

Chemokine CXCL1ChemokinesInterleukin-8Chemokine CCL2CXCL1 protein, humanCXCL8 protein, human

Autor:innen und Institutionen

  • Department of Clinical Sciences, Obstetrics and Gynecology, Umeå University, Umeå, Sweden.
  • Department of Obstetrics and Gynecology, Sundsvall County Hospital, Sundsvall, Sweden.
  • Department of Obstetrics and Gynecology, Istanbul Kanui Sultan Suleyman Training and Research Hospital, Istanbul, Turkey.
  • Department of Pathology, Istanbul Kanui Sultan Suleyman Training and Research Hospital, Istanbul, Turkey.
  • Department of Medical Biochemistry, Hamidiye Faculty of Medicine, University of Health Sciences Turkey, Istanbul, Turkey.
  • Department of Medical Biochemistry, Haydarpaşa Numune Health Application and Research Center, University of Health Sciences Turkey, Istanbul, Turkey.

Förderung

  • Department of Research and Development (FOU)
  • Region Västernorrland

Zitieren

APA

Sommar, A., Bahat, P. Y., Özaydin, I. Y., Güler, E. M., Bixo, M., Bäckström, T., Oral, E., & Turkmen, S. (2025). Chemokines and Their Association With Symptom Severity in Women With Endometriosis. American Journal of Reproductive Immunology, 94(3). https://doi.org/10.1111/aji.70156

Vancouver

Sommar A, Bahat PY, Özaydin IY, Güler EM, Bixo M, Bäckström T, et al. Chemokines and Their Association With Symptom Severity in Women With Endometriosis. American Journal of Reproductive Immunology. 2025;94(3). doi:10.1111/aji.70156

BibTeX
@article{Sommar2025,
  author = {Sommar, Anton and Bahat, Pinar Yalcin and Özaydin, Ipek Yildiz and Güler, Eray Metin and Bixo, Marie and Bäckström, Torbjörn and Oral, Engin and Turkmen, Sahruh},
  title = {Chemokines and Their Association With Symptom Severity in Women With Endometriosis},
  journal = {American Journal of Reproductive Immunology},
  year = {2025},
  volume = {94},
  number = {3},
  doi = {10.1111/aji.70156}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche